Lotus Pharmaceuticals (LTUS) Stock Price, News & Analysis

Company Overview

Lotus Pharmaceuticals, trading under the symbol LTUS on the OTC Market, is a Taiwan-based pharmaceutical company specializing in the research, development, manufacturing and marketing of prescription medications. The company’s core operations encompass both the production of a broad range of generic drugs and the advancement of novel compounds aimed at therapeutic areas such as oncology, central nervous system disorders, cardiovascular diseases and anti-infective treatments.

Lotus Pharmaceuticals offers multiple dosage forms, including tablets, capsules, injectables and sterile preparations, to meet the needs of hospital and retail pharmacy channels. The company maintains an active internal R&D program, collaborating with external research organizations and academic institutions to move new molecular entities from preclinical stages into clinical trials while continuously expanding its generic portfolio.

Headquartered in Tainan, Taiwan, Lotus Pharmaceuticals serves the domestic healthcare market and exports its products to key territories across Asia. By upholding international quality standards and pursuing strategic partnerships, the company aims to strengthen its geographic reach and enhance its pipeline of innovative and cost-effective therapeutic solutions.

Key Stats

• Today's Range: $0.0065 to $0.0073
• 50-Day Range: $0.0033 to $0.0111
• 52-Week Range: $0.0006 to $0.0111
• Volume: 26,452 shs
• Average Volume: 20,390 shs
• Market Capitalization: $17.19 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LTUS Stock Analysis - Frequently Asked Questions

How have LTUS shares performed this year?

Lotus Pharmaceuticals' stock was trading at $0.0060 on January 1st, 2025. Since then, LTUS stock has increased by 8.3% and is now trading at $0.0065.

How do I buy shares of Lotus Pharmaceuticals?

Shares of LTUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Lotus Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Lotus Pharmaceuticals investors own include Vodafone Group (VOD), TILT (TLLTF), SolarWinds (SWI), Spectra Energy Partners (SEP), NextEra Energy (NEE), Energy Transfer (ET) and Ameriwest Lithium (AWLID).

Company Calendar

• Today: 9/12/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:LTUS
• CIK: N/A
• Web: www.lotuspharma.com
• Phone: (941) 267-9684
• Fax: 86-10-6389-9867
• Employees: 230
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 2,644,520,000
• Free Float: N/A
• Market Cap: $19.30 million
• Optionable: Not Optionable
• Beta: -2.34